Christopher M. Mahoney

Current Therapeutic Strategies for Adipose Tissue Defects/Repair Using Engineered Biomaterials and Biomolecule Formulations

K. Marra, C. Yates, Christopher M. Mahoney, 2018, Front. Pharmacol..

Sustained Delivery of SB-431542, a Type I Transforming Growth Factor Beta-1 Receptor Inhibitor, to Prevent Arthrofibrosis

G. Vunjak‐Novakovic, G. Ateshian, C. Hung, 2021 .

Electrospun nanofibers of poly(ε-caprolactone)/depolymerized chitosan for respiratory tissue engineering applications

Jagannathan Sankar, N. Bhattarai, J. Sankar, 2016, Journal of biomaterials science. Polymer edition.

Adipose derived delivery vehicle for encapsulated adipogenic factors.

K. Marra, Christopher M Mahoney, Arta Kelmindi-Doko, 2017, Acta biomaterialia.

Nanofibrous Structure of Chitosan for Biomedical Applications

N. Bhattarai, J. Sankar, M. McCullough, 2012 .

Long-gap peripheral nerve repair through sustained release of a neurotrophic factor in nonhuman primates

D. Weber, D. Crammond, K. Marra, 2020, Science Translational Medicine.

The Role of Chemokines in Fibrotic Dermal Remodeling and Wound Healing

Z. Johnson, C. Yates, Christopher M Mahoney, 2018, Molecular and Translational Medicine.

Controlled dexamethasone delivery via double-walled microspheres to enhance long-term adipose tissue retention

J. Rubin, K. Marra, Arta Kelmendi-Doko, 2017, Journal of tissue engineering.

Synthesis and characterization of magnesium gluconate contained poly(lactic-co-glycolic acid)/chitosan microspheres

K. Marra, N. Bhattarai, J. Sankar, 2016 .